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General Information
The Editors of The Journal of Thoracic and Cardiovascular Sur-
gery aim to promote excellence in the discipline and educate those
practicing and interested in our specialty. To this end, the Journal
accepts submissions in the form of original articles, brief commu-
nications, review articles, clinical-pathological conferences, and
letters to the Editor on topics pertaining to the most recent devel-
opments in cardiothoracic transplantation, general thoracic sur-
gery, surgery for acquired and congenital cardiovascular disease
and technical and physiologic issues as they relate to the specialty.
The Journal commits to rigorous peer review, freedom from
commercial influence, and promotion of the highest ethical and
scientific standards in our specialty.
Editorial Policies
Review: Three or more referees review each article. Acceptance is
based on significance, originality, and validity of the material
presented. If the article is accepted for publication, editorial revi-
sions may be made to aid clarity and understanding without
altering the meaning. Authors are given the opportunity to name a
reviewer whom they believe is expert and impartial in their area of
interest.
Guidelines for Reviewers: Because more papers are submitted to
The Journal of Thoracic and Cardiovascular Surgery than can be
published, only the very best papers should be recommended for
publication. Accordingly, a manuscript should be evaluated not
only with respect to its scientific competence and accuracy, but
also its relative importance in the field of thoracic and cardiovas-
cular surgery and for its probable interest to our readership.
Among the issues to consider are:
● What is the importance of the research question or subject field
study?
● Are the methods and experimental techniques adequate?
● Do the results seem to be reliable and presented clearly?
● Is the discussion relevant?
● Are the conclusions reasonable?
● Are the illustrations and references appropriate and necessary?
● Is the abstract informative and written in a style that will make
it intelligible to readers who do not work in the specific area
addressed by the abstract?
● Is the writing clear and the organization of the paper sound?
● What is the originality of the work?
If you recommended that a paper be shortened, you should
indicate on the form “Comments to Authors” in which places it
could be abbreviated and which figures or tables could be omitted.
Please remember that it is the job of the copy editor to identify
typographical and syntactic errors. Please focus your “Comments
to Authors” on queries and constructive criticism. Do not put
statements in the “Comments to Authors” form regarding the
acceptability of the paper. If the editorial office or the other
reviewers decide to reject the paper, such statements could be
problematic.
Scientific Responsibility: Only those individuals who made direct
contributions to the intellectual content of the paper may be listed
as authors. Persons designated as authors should meet all of the
following criteria:
1. Conceived and planned the work that led to the paper or
interpreted the evidence presented, or both.
2. Wrote the paper, or reviewed successive versions and took
part in the revision process.
3. Approved the final version.
The authors should describe the role of the study’s sponsors in
the following areas:
1. The design of the study
2. The collection, analysis, and interpretation of the data
3. Writing the report
4. Making the decision to submit for publication
The JTCVS editorial staff will not consider for publication a
report in which the researcher did not have full access to the data,
the ability to analyze them independently from the sponsor, and
sole authority to make the final decision regarding publication. The
Editor may, if he deems it necessary, require a copy for verification
of its content.
After a manuscript is accepted for publication, no author can be
removed from the author list without the written permission of that
author.
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Conflict of Interest: When the proposed publication concerns any
commercial product, either directly or indirectly, the author must
include in the cover letter a statement (1) indicating that he or she
has no financial or other interest in the product or distributor of the
product or (2) explaining the nature of any relation between
himself or herself and the manufacturer or distributor of the
product. Other kinds of associations, such as consultancies, stock
ownership, or other equity interests or patent-licensing arrange-
ments, also must be disclosed. If, in the Editor’s judgment, the
information disclosed represents a potential conflict of interest, it
may be made available to reviewers and may be published at the
Editor’s discretion; authors will be informed of the decision before
publication.
Sources of outside support for research, including funding,
equipment, and drugs, must be named in the cover letter. The
role(s) of the funding organization, if any, in the collection of data,
its analysis and interpretation, and in the right to approve or
disapprove publication of the finished manuscript must be de-
scribed in the Methods section of the text.
Informed Consent: The Journal adheres to the principles set forth
in the Helsinki Declaration (www.wma.net/e/policy/17-c_e.html)
and holds that all reported research conducted with human partic-
ipants should be conducted in accordance with such principles.
Reports describing data obtained from research conducted in hu-
man participants must contain a statement in the Methods section
indicating approval by the institutional review board and affirma-
tion that informed consent was obtained from each participant. If
patients are identifiable from illustrations, photographs, case re-
ports, or other study data, release forms (or copies of the figures
with the appropriate release statement) giving permission for pub-
lication must be submitted with the manuscript.
Humane Animal Care: All papers reporting experiments using
animals must include a statement in the Methods section giving
assurance that all animals have received humane care in compli-
ance with the “Guide for the Care and Use of Laboratory Animals”
(www.nap.edu/catalog/5140.html). Papers submitted from outside
the United States must be in compliance with the guidelines
established by their country’s government or those of the National
Institutes of Health and must include a statement to that effect in
the Methods section.
Consultant Statistician and Statistical Methods: All manuscripts
with statistical analysis are required to undergo biostatistical re-
view to ensure adequate and appropriate study design, analysis,
interpretation, and reporting. The Journal requires that a biostat-
istician review these manuscripts prior to submission. The most
appropriate way to involve a biostatistician is as a consultant or
coauthor from the investigators’ home institution or collaborative
group. The individual must complete and sign the Statistical Col-
laboration/Review Release Statement, available online (www.
ctsnet.org/journals/jtcsstatisticalmethods.pdf) and published twice
yearly (January and July issues) in the Journal. Manuscripts may
undergo further biostatistical review by the Journal after submis-
sion. Additional information on statistical methods can be found in
“Uniform Requirements for Manuscripts Submitted to Biomedical
Journals” (www.icmje.org).
Copyright Statement: According to the Copyright Act of 1976, all
manuscripts must be accompanied by the Copyright Transfer and
Author Declaration Statement form that is available online at
www.ctsnet.org/journals/jtcscopyrightform.pdf and in each issue
of the Journal following the Information for Authors section. All
authors must sign this statement.
Article Preparation
Manuscripts must be written so that a reasonably well-informed
member of the thoracic surgical community can understand them.
The primary goal of the Journal is the dissemination of informa-
tion and education. Arcane content must be explained and consid-
ered understandable by the editorial staff. Articles are chosen
based on their probability of achieving this goal. Authors are
encouraged to follow the principles of clear scientific writing, such
as those described by Gopen and Swan.1
Original Research Articles: The Journal publishes original re-
search in surgery and translational physiology as it relates to
acquired and congenital cardiovascular disease, cardiothoracic
transplantation, and general thoracic surgery. Meritorious work
from closely related specialties, such as anesthesiology, molecular
biology, pathology, pulmonary medicine, cardiology, and perfu-
sion, will receive appropriate consideration if the linkage to our
specialty is clear.
Checklist
Cover letter
Manuscript category designation
Single-journal submission affirmation
Conflict of interest statement (if appropriate)
Sources of outside funding, equipment, drugs
Copyright Transfer/Author Declaration Statement
Permission to reproduce published material in all forms and
media or to cite unpublished data
Informed consent statement (in Methods)
Humane animal care statement (in Methods)
Funding agency’s role in data interpretation (in Methods)
Signed Statistical Collaboration/Review Release Statement
Original manuscript submitted via jtcvs.editorialmanager.com
Title page
Title of article
Full name(s), academic degrees, and affiliation(s) of authors
Corresponding author
Telephone (business and home), fax, and E-mail address
for corresponding author
Word count
Abstract (250 words; double-spaced)
Ultramini-abstract (50 words; double-spaced)
Text (double-spaced)
References (double-spaced; separate pages)
Tables (double-spaced; separate pages)
Figure legends (double-spaced; separate pages)
Figures (separate files; no paperclips on hardcopy; properly
identified)
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Article length must be no longer than 6 printed pages, not includ-
ing title and abstract. The following approximations between
printed pages and typed pages are offered to help you calculate the
number of printed pages your typed manuscript will translate to:
● 1 printed page  3.7 typed 8.5  11 pages, double-spaced
(approximately 250 typed words per page)
● 0.67 printed page  30 typed references (maximum allowed;
double-spaced)
● 1 printed page  4 tables or figures with legends
Clinical-Pathological Conference: This can be an important ed-
ucational tool and has recently been added to the content of the
Journal. Acceptance will be based upon the learning opportunities
presented by careful exposition of the case material, scholarly use
of the literature to present treatment options, and discussion of
patient outcome in the context of evidence-based medicine as the
determinant for management and diagnosis-based issues. Unusual
or rare entities are better treated as brief communications. Content
should include appropriate illustrative material and may be sup-
plemented by additional illustrative content that will appear in
electronic form and may include digitized videos and illustrations.
Brief Communications: The Editors are interested in brief clinical
contributions containing substantive information concerning clin-
ical studies or a pertinent observation. The article should contain
no more than 750 words and 2 tables or figures and no more than
5 references. These submissions will be chosen on their discussion
and educational value and on their scholarly use of the literature.
Evolving Technology: Submissions to this section provide an
opportunity to make the surgical community aware of novel tech-
nical additions to our specialty prior to the time that such innova-
tions have undergone traditional trials and early application. Sub-
missions to this section will be accepted on the basis of novel and
important approaches to issues in our specialty. At times, work at
a theoretical level will be considered. Communications should be
brief (no more than 750 words) and are not required to contain
references, although their use is not discouraged.
Letters to the Editor: Readers are encouraged to submit commen-
tary on articles published in the Journal. Letters should be of broad
interest to readers and not designed to “split hairs.” Conflicting
opinions on broad issues are particularly welcome when documen-
tation is possible. Letters may be published together with a reply
from the original author. If the original author does not respond, a
notation indicating “Response declined” will be published. Letters
to the Editor should not exceed 500 words, 1 figure or table, 3
authors, and 5 references. Substantive Letters to the Editor are
indexed in Index Medicus.
Manuscript Preparation
Title Page: Provide a concise, informative title, with no unneces-
sary words (eg, Studies in . . .). List all authors’ academic degrees
and affiliations. Include all sources of funding for the work and
complete name, address, business and home telephone and fax
numbers, and E-mail address of the corresponding author. Also
include article word count.
Abstract: The structured abstract should be limited to 250 words,
should not include acronyms or abbreviations, and should contain
the following sections:
1. Objective(s): describe the hypothesis or the purpose of the
study
2. Methods: identify the study design and statistical methods
used
3. Results: describe the outcome of the study and the statistical
significance, if appropriate
4. Conclusions: state the significance of the results
Please provide a word count and do not use acronyms or
abbreviations.
Ultramini-abstract: Provide 1 to 3 sentences of no more than 50
words total, containing the essence of the manuscript, to include
immediately beneath the title of the paper in the table of contents.
Units of Measurement: Report measurements of length, height,
weight, and volume in metric units (meter, kilogram, or liter) or
their decimal multiples. Give temperatures in degrees Celsius and
blood pressures in millimeters of mercury. All hematologic and
clinical chemistry measurements should be reported in the metric
system in terms of the International System of Units (SI). The
authors should also add alternate or non-SI units before publica-
tion. See www.acponline.org/journals/resource/unifreqr.htm for
more details.
Abbreviations: Except for units of measurements, abbreviations
are discouraged. Abbreviations that are used should be defined at
first mention. Internationally accepted abbreviations such as AIDS,
DNA, SD, and TNM need not be defined. For commonly accepted
abbreviations, word usage, symbols, and so forth, please consult
Scientific Style and Format2 and the American Medical Associa-
tion Manual of Style.3
References: Limit references to directly pertinent published works
or papers that have been accepted for publication. Number refer-
ences serially in the text and list them, on a separate sheet of paper,
double-spaced, at the end of the paper in numerical order. Refer-
ence format should conform to that set forth in “Uniform Require-
ments for Manuscripts Submitted to Biomedical Journals”
(www.acponline.org/journals/resource/unifreqr.htm) and journal
abbreviations should conform to the style used in the Cumulated
Index Medicus. The style of citation should be as follows:
Journals: authors’ last names and initials; title of article; journal
name; date; volume number, and inclusive pages (list all authors
when six or fewer; when seven or more, list six and add et al):
Graeber GM, Gupta NC, Murray GF. Positron emission
tomographic imaging with fluorodeoxyglucose is effica-
cious in evaluating malignant pulmonary disease. J Tho-
rac Cardiovasc Surg. 1999;117:719-27.
Lytle BW, Blackstone EH, Loop FD, Houghtaling PL,
Arnold JH, Akhrass R, et al. Two internal thoracic artery
grafts are better than one. J Thorac Cardiovasc Surg.
1999;117:855-72.
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Books: authors’ last names and initials; chapter title, editor’s
name, book title, edition, city, publisher, date, and pages:
Mollnes TE. Analysis of in vivo complement activation:
In: Herzenberg LA, Weir DM, Herzenberg LA, Black-
well C, editors. Weir’s handbook of experimental im-
munology. Volume 78, 5th ed. Boston: Blackwell Sci-
ence; 1997, p. 78.1-78.8.
Unpublished data and personal communications should be cited
only in the text, not as a numbered reference. Authors wishing to
cite unpublished material must have a letter of permission from the
originator of the communication to do so. This letter should be
submitted with the manuscript.
Figures: For help with preparing electronic artwork for both
on-screen review and eventual publication, see the information
page created by Elsevier Inc. (www.elsevier.nl/homepage/sab/art-
work).
Figures must be of professional quality. When possible, please
use or supply first-generation artwork. Number figures in the order
of their appearance in the text.
NOTE: JTCVS will need print quality copies of artwork for
each figure at a later stage (with the final version) only if the
paper is accepted for publication.
The Journal will reproduce free of cost to the author a reason-
able number of black and white illustrations. Authors are asked to
assume the cost of printing their color illustrations. When color
illustrations accompany a manuscript, the publisher will contact
the author with the exact cost of including color illustrations. The
decision whether or not to include color is the author’s.
Efficient Use of Space in Figures:
● Eliminate blank spaces that contain no information (eg, delete
points on the x and y axes that do not contain data)
● Do not border a figure or a key with a box
● If they fit, place keys that apply to the figure within the figure
itself (without a box); if the key does not fit in the figure, place
it at the end of the legend
● Create figures in scale with each other to the extent possible
Effective Formatting in Figures:
● Do not use background horizontal lines
● Avoid 3-dimensional art
● Make sure both axes are labeled
● Most art will be one column wide. Ensure that all data and type
within a figure are sized according to this guideline to the extent
possible
● Use uppercase and lowercase type: It is much easier to read
than all capital letters
● Vary the size and weight of the type of the various components
of the figure, eg, set titles in bold and at least 2 point sizes larger
than axes numbers and labels
● Use a consistent type face throughout (Times Roman is the
most readable font; avoid sans serif types such as Courier)
● Use a bold typeface for emphasis; it is much more readable that
italics or underlining
● Avoid gray shading; it does not reproduce well
● Make lines thick enough to ensure adequate reproduction (ex-
tremely thin lines do not reproduce well.
General Instructions:
● Identify print proofs of figures on the back with figure number
and name of the first author; when necessary, indicate the top
with an up arrow
● Please include hardware and software information, in addition
to the file names, with figures submitted electronically or on
disk
● For figures submitted in electronic format, all images should be
at least 5 inches wide. Images should be provided in EPS or TIF
format (for those mailed to the Editorial Office, on Zip Disk,
CD, floppy, Jaz, or 3.5 Magneto Optical)
● Graphics software such as Photoshop and Illustrator, not pre-
sentation software such as PowerPoint, CorelDraw, or Harvard
Graphics, should be used to create art
● Color images need to be CMYK, at least 300 dpi, with a digital
color proof, not a color laser print or color photocopy. Note:
This proof will be used at press for color reproduction
● Gray scale images should be at least 300 dpi accompanied by
a proof
● Line art (black and white or color) and combinations of gray
scale and line art should be at least 1200 dpi and accompanied
by a proof
● For best reproduction, screening, shading, and lettering on a
dark background should be avoided.
Tables: Tables should be self-explanatory and should supplement,
not duplicate, the text. Type on pages separate from the text.
Provide a brief title for each. Abbreviations used in table should be
defined at the bottom of the table.
Cover Letter: Include with the manuscript a cover letter that
provides (1) the category of manuscript (eg, original research,
Brief Communication, Letter to the Editor); (2) statement that the
material has not been previously published or submitted elsewhere
for publication; (3) information about any personal conflicts of
interest of any of the authors; and (4) names of sources of outside
support for research, including funding, equipment, and drugs (see
Conflict of interest above). You may also submit the name of one
reviewer of your choice. You should include that individual’s
mailing address, telephone number, fax number, and E-mail ad-
dress. You should know that the reviewer will be asked to review
the manuscript at your request but will also be informed that his or
her identity will be kept confidential.
Manuscript Submission
Electronic Submission: All manuscripts must be submitted via
Editorial Manager (http://jtcvs.editorialmanager.com) and
should include the following items (as appropriate):
● Cover letter
● Abstract and mini-abstract
● Title page and manuscript using word processing file (pdf files
are not acceptable)
● Tables (tables may either be included in the file with the
manuscript or attached as separate files)
● Figures (attach as separate files); hard copy requested if manu-
script is accepted for publication
The following items that accompany the manuscript may be
scanned and submitted electronically or submitted by mail if
scanning is not an option:
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● Copyright Transfer/Author Declaration Statement
● Permission to reproduce published material (if applicable)
● Statistical Collaboration/Review Statement (if applicable)
Note: To view your manuscript in PDF format on Editorial
Manager, you must have Adobe Acrobat Reader 5.0 installed
on your computer.
General Guidelines:
● Format all text elements as double spaced for easier reading
● Insert page breaks between the title page, abstract, ultramini-
abstract, and first page of text.
● Begin text, acknowledgements, references, and figure legends,
respectively, on separate pages.
● Begin each table on a separate page.
● Write text in clear concise language, using accepted standards
of English style and usage. Define unfamiliar or new terms
when first used and avoid use of jargon, cliche´s, and laboratory
slang.
● NOTE: It is the author’s responsibility to ensure that each
submitted version of the manuscript is the correct version and
that each version is clearly marked.
● Include on the title page the title of the article and the author(s)
name(s), degree(s), and institutional affiliation(s) as well as the
name, business and telephone number, fax number, and E-mail
address of the corresponding author. Where necessary, identify
each author’s affiliation by superscript numbers matched to the
appropriate institutions.
Revised Manuscripts:
● Revised manuscripts must be submitted in three parts as word-
processing files (pdf files are not acceptable): (1) cover letter
with responses to reviewers’ comments; (2) revised, marked
manuscript showing additions and deletions; (3) revised, un-
marked manuscript
● The organization of a revised manuscript is very important in
the review process. Most manuscripts submitted to the Journal
are revised at least once. Please structure your response as
follows:
▪ The reviewer’s comment to which you are responding
▪ Your response
▪ How that response is manifest in the revised manuscript
▪ A response to each and every reviewer comment
Manuscript Processing
Acknowledgment of Receipt: Each submission is assigned a
unique number and acknowledged by E-mail. The editorial office
considers the manuscript number a confidential communication,
which should be given only to other authors of the paper. The
editorial office staff releases information about manuscripts only to
authors who provide the manuscript number. Information about a
specific manuscript can be obtained via Editorial Manager only by
the corresponding author or his designated representative who has
access to his personal username and password.
Return of Manuscripts: Neither unaccepted papers nor their orig-
inal figures, photographs, and slides are returned to the authors
unless this is specifically requested in the cover letter. Illustrations
for papers that have been accepted for publication will not be
returned unless specifically requested by the author.
Print References
1. Gopen GD, Swan JA. The science of scientific writing. Am Sci.
1990;78:550-8.
2. Scientific Style and Format: The CBE Manual for Authors,
Editors, and Publishers, 6th ed. New York: Cambridge Univer-
sity Press; 1994.
3. Iverson, Cheryl, et al, editors. American Medical Association
Manual of Style, 9th ed. Baltimore: Williams and Wilkins,
1998.
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Statistical Methods
Because data and their analyses often constitute thesupporting evidence for inferences drawn from stud-ies submitted to the Journal, the Editors remindauthors that all manuscripts with statistical analysesundergo statistical review by the Journal. The review
includes study design, analysis, interpretation, and reporting. The
manuscripts are not published without an acceptable rating by the
statistical editorial staff. Therefore, to minimize revision and de-
lays, authors should request review of such manuscripts by a
statistician prior to submission. This is best done by involving a
statistician as a collaborator from the inception to completion of
the study.
The Editors subscribe to the statistical guidelines contained in
the “Uniform Requirements for Manuscripts Submitted to Bio-
medical Journals” (Ann Intern Med. 1997;126:36-47). These are as
follows:
Describe statistical methods with enough detail to enable
a knowledgeable reader with access to the original data to
verify the reported results. When possible, quantify find-
ings and present them with appropriate indicators of mea-
surement error or uncertainty (such as confidence inter-
vals). Avoid relying solely on statistical hypothesis
testing, such as the use of P values, which fails to convey
important quantitative information. Discuss the eligibility
of experimental subjects. Give details about randomiza-
tion. Describe the methods for and success of any blind-
ing observations. Report complications of treatment. Give
numbers of observations. Report losses to observation
(such as dropouts from a clinical trial). References for the
design of the study and statistical methods should be to
standard works when possible (with pages stated) rather
than to papers in which the designs or methods were orig-
inally reported. Specify any general-use computer pro-
grams used.
Put a general description of methods in the Methods sec-
tion. When data are summarized in the Results section,
specify the statistical methods used to analyze them. Re-
strict tables and figures to those needed to explain the
argument of the paper and to assess its support. Use
graphs as an alternative to tables with many entries; do
not duplicate data in graphs and tables. Avoid non-techni-
cal uses of technical terms in statistics, such as “random”
(which implies a randomizing device), “normal,” “signifi-
cant,” “correlations,” and “sample.” Define statistical
terms, abbreviations, and most symbols.
We recognize that there are a number of schools of differing
statistical philosophy, and we take these differences into account.
Nevertheless, over the years, a number of specific items have been
raised repeatedly by statisticians when reviewing manuscripts. The
Editors have compiled a list of these and present them in the form
of guidelines, with the intent of being helpful to authors, not
prescriptive. The guidelines have been formulated as a checklist
and appear twice yearly, in the January and July issues.
Statistical Guidelines for Manuscript Submission
Authors should prepare manuscripts in light of the guidance pro-
vided in “Notes from the Editors” (J Thorac Cardiovasc Surg.
1996;112:209-20). Authors should also consult published check-
lists such as Gardner MJ, Machin D, Campbell MJ, “Use of Check
Lists in Assessing the Statistical Content of Medical Studies”
(BMJ. 1986;292:810-2) and Bailar JC, Mosteller F, “Guidelines
for Statistical Reporting in Articles for Medical Journals” (Ann
Intern Med. 1988;108:226-73). For papers reporting events after
heart valve procedures, consult Edmunds LH Jr, Clark RE, Cohn
LH, Grunkemeier GL, Miller DC, Weisel RD, “Guidelines for
Reporting Morbidity and Mortality After Cardiac Valvular Oper-
ations. Ad Hoc Liaison Committee for Standardizing Definitions
of Prosthetic Heart Valve Morbidity of The American Association
for Thoracic Surgery and The Society of Thoracic Surgeons”
(J Thorac Cardiovasc Surg. 1996;112:708-11). For reports of
randomized clinical studies, consult Begg C, Cho M, Eastwood S,
Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz K, Simel
D, Stroup DF, “Improving the Quality of Reporting of Random-
ized Controlled Trials” (JAMA. 1996;276:637-9). See also Pianta-
dosi S, Gail M, “Statistical Issues Arising in Thoracic Surgery
Clinical Trials.” In: Pearson FG, Deslauriers J, Ginsberg RJ,
Hiebert CA, McKneally MF, Urschel HC Jr, editors. Thoracic
Surgery. New York: Churchill Livingstone; 1995. p. 1652-70, and
Kirklin JW, Barratt-Boyes BG, “The Generation of Knowledge
From Information, Data and Analyses.” In: Cardiac Surgery, New
York: Churchill Livingstone; 1993. p. 249-82.
Checklist
Notation and terminology. Explain meaning of notations such as
SE, SD, CL, or CI in abstract, methods, and tables when they first
appear. Distinguish between a variable, an item that can take on
different values for each subject or observation, such as tempera-
ture and blood pressure, and a parameter, a constant, such as the
mean. Distinguish between prevalence, a proportion of subjects
or observations, and incidence or rate, a quantity expressed per
unit of time. Distinguish between multivariable, referring to
several predictor or explanatory variables or risk factors, and
multivariate, referring to simultaneous analysis of several out-
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come variables. The latter is a relatively recent change in statistical
definitions. An accessible source of statistical terms can be found
in Piantadosi S, Kirklin J, Blackstone E. Statistical Terminology
and Definitions. In: Pearson FG, Deslauriers J, Ginsberg RJ,
Hiebert CA, McKneally MF, Urschel HC Jr, editors. Thoracic
Surgery. New York: Churchill Livingstone; 1995. p. 1649-52.
Distinguish between descriptive statistics and expression of un-
certainty of parameter estimates. When describing the values for
a variable (eg, baseline information), descriptive statistics such as
median and quartiles or the mean and standard deviation are
appropriate. In particular, when the distribution of values is
skewed, nonparametric descriptors such as quartiles are appropri-
ate, not mean and standard deviation. In contrast, the uncertainty of
parameter estimates is expressed commonly in terms of confidence
limits (intervals) or, when these are symmetric, the standard error.
P values. Although it is not possible with all statistical tests, and
although it is contrary to some statistical philosophies, we recom-
mend use of exact P values unless P .001 or P .2 as measures
of evidence. Thus, we recommend against use of “P  .05 was
considered significant” or the abbreviation NS, or symbols repre-
senting various levels of statistical significance.
Authors sometimes interpret large P values to mean, “There is
no difference between groups.” This is generally contrary to the
facts because differences are evident. We prefer the use of the
phrase, “The differences could be due to chance (P  .2).”
The term “significant” is ambiguous, because it fails to distin-
guish so-called statistical from clinical significance. We recom-
mend against the use of the term “significant,” suggesting that a
synonym such as “important” be used to signify “clinical signifi-
cance.” Statistical significance often can go unstated when accom-
panied by a P value.
P values alone do not convey the magnitude of the effect or
difference, nor its precision. Therefore, we will recommend the use
of estimates of strength (eg, coefficients, odds ratios, hazard ratios)
and confidence limits (intervals), tolerance intervals, or credibility
intervals to convey this information. Use of these intervals is
particularly important when the conclusion is that no effect or
association was observed (equivalence).
Other specific expressions of uncertainty. In many settings, par-
ticularly when the number of patients or subjects is small, propor-
tions should be accompanied by confidence limits (intervals). We
do not prescribe a specific confidence interval, such as 95%, or
intervals equivalent to1 standard deviation, since the appropriate
confidence limits may vary with the situation. A consistent schema
for expressive variability would include 1 standard deviation for
normally distributed continuous variables, 15 and 85 percentiles
for skewed distributions, and 70% confidence limits for propor-
tions. Increasingly, approximations to parameter estimation and
measures of uncertainty are being supplemented by computer-
intensive resampling (bootstrap) methods.
Presentation of time-related events. In most circumstances, we
recommend that the following information accompany presenta-
tions of time-related events: point estimates, preferably at the time
of each event using a product limit method; asymmetric confidence
limits at periodic intervals; and the number of patients at risk at
periodic intervals.
Nonrandomized comparisons. Unlike experimental comparison
studies that nearly always should be randomized, randomization in
the clinical setting is often neither feasible nor ethical. Increas-
ingly, multivariable matching methods for adjusting for ascertain-
able selection bias are becoming prevalent, well understood, and
accessible (eg, use of propensity scores).
Multiple group comparisons and repeated measurements. In
comparing three or more groups, statistical methods appropriate
for multiple group comparisons and contrasts should be employed.
If these groups have a natural ordinal relationship one with an-
other, then methods that account for trend should be employed.
When multiple measurements are obtained across time in the same
patient or subject, methods of longitudinal data analyses (a rela-
tively new field of statistics that has supplanted traditional repeated
measures methodology) are recommended.
Multivariable analyses. Many studies lend themselves to methods
that take into account simultaneously multiple variables (risk fac-
tors, predictor variables, independent variables, co-variables). Re-
ports of multivariable analyses must state the model used, all
variables that were examined, how the variables were coded in the
final models, the extent of testing for interactions, the degree to
which conformity to a linear gradient (for continuous or ordinal
variables) was examined and accounted for, the degree to which
the assumption of proportional hazards was tested when using such
models, colinearity of variables, possibility of overfitting, and
methods used for model validation.
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